Nephro Care India Share Price
Start SIP in Nephro Care India
Start SIPNephro Care India Performance
Day Range
- Low 266
- High 275
52 Week Range
- Low 171
- High 379
- Open Price273
- Previous Close279
- Volume27200
Nephro Care India Investment Rating
-
Master Rating:
-
Nephro Care India Ltd has an operating revenue of Rs. 49.57 Cr. on a trailing 12-month basis. An annual revenue growth of 61% is outstanding, Pre-tax margin of 23% is great, ROE of 29% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around 1% and 1% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 26% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 105 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2024 | Mar 2023 |
|---|---|---|
| Total Revenue Annual Cr | 28 | 17 |
| Operating Expenses Annual Cr | 21 | 13 |
| Operating Profit Annual in Cr | 6 | 4 |
| Depreciation Cr | 1 | 1 |
| Interest Annual Cr | 0 | 0 |
| Tax Annual Cr | 2 | 1 |
| Net Profit Annual Cr | 4 | 2 |
Nephro Care India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹274.76
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹273.98
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
Nephro Care India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 272.17 |
| Second Resistance | 277.58 |
| Third Resistance | 280.67 |
| RSI | 49.13 |
| MFI | 44.14 |
| MACD Single Line | 7.73 |
| MACD | 2.97 |
| Support | |
|---|---|
| First Support | 263.67 |
| Second Support | 260.58 |
| Third Supoort | 255.17 |
Nephro Care India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 27,200 | 2,239,920 | 82.35 |
| Week | 28,160 | 2,144,102 | 76.14 |
| 1 Month | 116,343 | 7,580,901 | 65.16 |
| 6 Month | 108,189 | 6,732,578 | 62.23 |
Nephro Care India Result Highlights
Nephro Care India Synopsis
NSE-Medical-Hospitals
Nephro Care India belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 27.23 Cr. and Equity Capital is Rs. 11.90 Cr. for the Year ended 31/03/2024. Nephro Care India Ltd. is a Public Limited Listed company incorporated on 08/07/2014 and has its registered office in the State of West Bengal, India. Company’s Corporate Identification Number(CIN) is U85100WB2014PLC202429 and registration number is 202429.| Market Cap | 440 |
| Sales | 27 |
| Shares in Float | 0.64 |
| No of funds | |
| Yield |
| Book Value | 21.14 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | 99 |
| Alpha | 0.96 |
| Beta | 1.81 |
Nephro Care India Shareholding Pattern
| Owner Name |
|---|
Nephro Care India Management
| Name | Designation |
|---|---|
| Dr. Pratim Sengupta | Managing Director |
| Dr. Pritam Sengupta | Director |
| Dr. Sutapa Sen | Director |
| Mr. Saikat Biswas | Independent Director |
| Mr. Sudip Barman | Independent Director |
| Mr. Alo Sengupta | Independent Director |
| Mr. Sandeep Shridhar Ghate | Addnl. & Non Exe.Director |
| Mr. Debashish Ghoshal | Addnl. & Non Exe.Director |
Nephro Care India Forecast
Price Estimates
Nephro Care India Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-20 | Audited Results | To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
| 2024-07-19 | Others | To consider other business matters |
Nephro Care India FAQs
What is Share Price of Nephro Care India ?
Nephro Care India share price is ₹266 As on 08 September, 2024 | 05:27
What is the Market Cap of Nephro Care India ?
The Market Cap of Nephro Care India is ₹439.8 Cr As on 08 September, 2024 | 05:27
What is the P/E ratio of Nephro Care India ?
The P/E ratio of Nephro Care India is As on 08 September, 2024 | 05:27
What is the PB ratio of Nephro Care India ?
The PB ratio of Nephro Care India is 29.3 As on 08 September, 2024 | 05:27